Delivery Order SPE2DB20D1100-SPE2DB25FD5U8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) under a firm fixed-price contract valued at $5,724.78. The award was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,914.29 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count packaging) on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,014.61 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) on April 29, 2025, with a completion date of April 30, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order valued at $9,503.28 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed price, competitively awarded delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $29,726.93 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90 count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $9,600.47 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (30-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price, competitively awarded delivery order was issued with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,855.36 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) with a firm fixed price structure. The contract is non-set-aside and competitively awarded, with an ultimate completion date of September 2, 2025. AmerisourceBergen will perform this delivery order from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,221.08 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) under a firm fixed price arrangement. The award was issued on September 19, 2025, with an ultimate completion date of September 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded procurement in support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,291.93 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units). This competitively awarded, firm fixed-price contract was issued on September 3, 2025, with an ultimate completion date of September 4, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting the competitive nature of...
- The Defense Logistics Agency awarded a delivery order valued at $13,881.40 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90 count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD5U8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $38,627.45 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count) on July 22, 2025, with completion expected by July 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order under its broader relationship with the DLA as a critical federal medical procurement vendor. This delivery order represents a small transaction within AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including support to the Defense Health Agency and U.S. Coast Guard. The contractor's extensive portfolio of federal medical supply awards demonstrates its established capability to meet competitive procurement requirements across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.6k | 7/22/25 |